Hana Lahrech1, Manuel Petit1, Sandra Pierre1, Maxime Leclercq1, Lionel Marc Broche2, and François Berger1
1BrainTech Lab INSERM U1205, Grenoble, France, 2University of Aberdeen, Aberdeen, United Kingdom
Synopsis
In FFC-NMR, R1-dispersion curves of biological systems frequently show quadrupolar peaks (QP) between 1.5 and 3.5 MHz that correspond to the
cross relaxation of water 1H and protein 14N. QP of glioma invasion tissues (Glio6 and Glio96 mouse models) and of
high glioma proliferation (U87 model) were acquired ex vivo and compared to cell pellets in vitro, showing significant differences. This result suggests that QP signals are intracellular, a
result which was confirmed by measurements of cells after trypsin treatment which
showed unchanged QP amplitude. This result highlights the potential of the QPs
as an intracellular biomarker of glioma invasion.
Objective
In biological systems, R1-dispersion curves (R1=1/T1 versus 1H Larmor frequency ν0) acquired by Fast-Field-Cycling NMR (FFC-NMR) often exhibit local R1 enhancements between 1.5 and 3.5 MHz, called quadrupolar peaks (QP) that result from quadrupolar interactions between nitrogen 14 of amino-acids in proteins and water protons (1H-14N)1. This study is focused on glioma, an aggressive cerebral tumor, with two objectives: (i) to describe if (14N-1H) QPs signals can discriminate between invasion and proliferation tissues. To test this, we used two glioma mouse models, Glio6 and Glio96, validated as invasion/migration models2,3, compared with the U87 characterized by a high glioma proliferation. (ii) To determine the intra- or extra-cellular origin of the proteins involved in the QP. To that purpose, glioma tissues characterized by their extra and intracellular compartments were compared to cell pellets with relaxation dominated by intracellular compartments. In parallel, we performed additional FFC and QP measurements of cells treated by trypsin, a digestive enzyme of the serine proteases family that breaks down proteins. Trypsin was specifically used because it is an extracellular biochemical substance that does not cross cell membranes and therefore can only degrade the extracellular compartment.Subjects and Methods
Cell culture,
cell pellet and Trypsin treatment: Glio6 and Glio96 cell lines were
obtained from human surgical glioma resection prior to this work. Both
were grown under hypoxia in 3% O2 and
5% CO2 in untreated flask with DMEM/F-12 (1:1) + GlutaMAX supplemented
with BFGF and EBF growth factors (20ng/ml). U87 glioma
cells (ATCC HTB-14) were grown in 5%
CO2 under 20% O2 in DMEM + GlutaMAX (Gibco) and 10% fetal bovine
serum and penicillin-streptomycin (100 U/ml).
Cell pellets were obtained
after centrifugations (5min, 1200rpm) and removing the supernatant. For Glio6
and Glio96, we added 1 ml cell dissociation solution and washed 5 min later, resuspended
twice with 4 ml and 1ml PBS respectively, centrifuged and removed the
supernatant. 20 to 40.106 cells were
used for FFC-NMR measurements, acquired 40 min after preparations.
For Trypsin
experiments, the cells were treated by adding 20-fold
excess of trypsin by weight.
Cells were prepared at 37˚C
and cell viability was assessed using trypan blue exclusion method before and
after FFC-NMR acquisitions.
Animal
models: All animal
procedures were conducted according to
the license C3818510003). Mouse-glioma models were obtained using immune-deficient
nude-mice (30 to 35 g). Glioma cells were injected into the right caudate nucleus under isoflurane (3%). In vivo
MRI follow-up was performed
at 4.7T with T2W- RARE sequence (TR/TE=3500/33
ms), every week during
the first month and every 2 days during the second and the third months. At late stage, brains were
removed (U87 n=11, Glio6 n=6, Glio96 n=7) and glioma tissues
extracted (30-210mg) and stored
at -80°C.
FFC-NMR: FFC-NMR
as described in Figure 1 was performed using a Stelar SPINMASTER-2000
relaxometer with a 10 mm bore diameter. Samples were put in 5mm diameter
NMR tube. To increase SNR we
accumulated 128 echoes of a Carr–Purcell–Meiboom–Gill (CPMG) sequence
with 10ms echo-time. We used 30 evolution
fields with logarithmic sampling between 5KHz and 30MHz. For each field
the magnetization
was measured over 12 evolution times selected logarithmically between
0.01 and
4 times the estimated T1 value. QP were acquired between 1.5 and 3.5MHz with a high
sampling (n=30). The total time of both acquisitions: 90min.
FFC analysis: The
amplitude of the QP was estimated after subtracting the
background contribution, fitted with a power-law model4, and analyzed according to reference5. Comparison between the different groups was assessed
using the Student test at p<0.05 level while the normality was ensured with
the Kruskal-Wallis
(KS).Result
Figure 2 displays the
average R1-dispersion
curves of the three glioma tissues. As reported in our previous work6,
this is lower for invasive glioma than for proliferative ones, as
quantified by the vertical offset (A). Additionally, the exponent of the
power
law β also discriminates invasion from proliferation, as expected since
it relates to water molecular dynamics. In all curves the QP signal was
present
and its amplitude was also discriminative of invasion and proliferation
(p<0.05). Figure 3A compares the R1-dispersion curves of
glioma
tissues with their corresponding cell pellets and details the QP signal
after subtraction
of the curve background. Figure 4 is a table which reports the statistical
analyses testing for differences between glioma tissue and their
corresponding cell pellets. This is particularly marked for the peaks
amplitude
(AQP) which is related to the protein concentrations7, meaning that
proteins
responsible for QP are intracellular. Indeed, under trypsin treatment,
(1H-14N) QP of cells remain unchanged (Figure 3B), confirming
thereby the intracellular origin of these signals.Conclusion
From this study, we can conclude that FFC-NMR is an
appropriate tool to discriminate invasion from proliferation. This study
especially
demonstrates that the (1H-14N) QP
peak signals predominantly arise in glioma from proteins localized
inside the
cells. This study aimed to determine the origins of the QP signals which
are modulated
by motion of the protein backbones, and
constitutes an important step when exploring the role of this parameter
as a
new glioma biomarker of large intracellular proteins.Acknowledgements
This project is as part of the
European H2020 PHC-11-2015 IDentIFY project 668119.References
1. Kimmich R, Nusser W, Winter F. In vivo NMR field-cycling
relaxation spectroscopy reveals 14N1H relaxation sinks in the backbones of
proteins. Phys Med Biol. 1984;29(5):593-596.
doi:10.1088/0031-9155/29/5/011
2. Gimenez U, Perles-Barbacaru A, Millet A, et al. Microscopic
DTI accurately identifies early glioma cell migration: correlation with
multimodal imaging in a new glioma stem cell model. NMR Biomed.
2016;29(11):1553-1562.
3. Dreyfus M, El-Atifi M, Court M, et al. Reprogramming glioma
cell cultures with retinoic acid: Additional arguments for reappraising the
potential of retinoic acid in the context of personalized glioma therapy. Glioma.
2018;(2):66-78.
4. Bottomley PA, Hardy CJ, Argersinger RE, Allen moore G. A
review of 1H nuclear magnetic resonance relaxation in pathology: Are T1 and T2
diagnostic? Med Phys. 1987;14(1):1-37.
5. Fries PH, Belorizky E. Simple expressions of the nuclear
relaxation rate enhancement due to quadrupole nuclei in slowly tumbling
molecules. J Chem Phys. 2015;143(4):044202.
6. Petit M, Pierre S, Leclercq M, et al and Lahrech H. FFC-NMR a Promising
Tool to Discriminate Infiltrative Tumour Cells from Solid Tumours: A Study of
Three Glioma Mouse Models. ISMRM/ESMR, Paris (2018).
7. Broche LM, Ismail SR, Booth NA, Lurie DJ. Measurement of
fibrin concentration by fast field-cycling NMR. Magn Reson Med.
2012;67(5):1453-1457. doi:10.1002/mrm.23117